+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Complicated Intra-Abdominal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Intra-Abdominal Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Necrotizing Enterocolitis - Pipeline Insight, 2025 - Product Thumbnail Image

Necrotizing Enterocolitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Shigellosis - Pipeline Insight, 2025 - Product Thumbnail Image

Shigellosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ulcerative Proctitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Proctitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Gastritis - Pipeline Insight, 2025 - Product Thumbnail Image

Gastritis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Malignant Ascites - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Ascites - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Idiopathic Constipation (CIC) - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Idiopathic Constipation (CIC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Irritable Bowel Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Hemorrhoids - Pipeline Insight, 2025 - Product Thumbnail Image

Hemorrhoids - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Severe Hypoglycemia - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Hypoglycemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Short Bowel Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Short Bowel Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025 - Product Thumbnail Image

Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Short Bowel Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Short Bowel Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 66 Pages
  • Global
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more